Clear Street’s Apellis Pharmaceuticals APLS Stock Holding History

Clear Street’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-350,000	Closed	–	–	1396
2026 Q1	$0	Buy	+350,000	New	+$7.54M	﹤0.01%	1107

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Clear Street's APLS Position: Q2 2026 in Review

Clear Street sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 350,000 shares.

Clear Street first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $0 in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Clear Street reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Clear Street sold 350,000 Apellis Pharmaceuticals shares in Q2 2026.
Clear Street first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Clear Street's Apellis Pharmaceuticals position peaked at $0 in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.